Related Experiment Video
Updated: Oct 2, 2025
05:06
Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
1.2K
Recent advances on nanoparticle-based therapies for cardiovascular diseases
Rema Sreenivasan Soumya1, Kozhiparambil Gopalan Raghu1
1Biochemistry and Molecular Mechanism Laboratory, Agroprocessing and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, Kerala, India.
Journal of Cardiology
|February 25, 2022
Summary
Nanoparticles offer promising cardiovascular disease (CVD) therapies due to their unique properties. Nanotechnology, especially polymer-based nanomaterials, shows potential for efficiently treating various cardiac disorders.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Cardiology
Background:
- Cardiovascular diseases (CVD) pose a significant global health challenge.
- Nanoparticles offer unique advantages for CVD treatment due to their size and tunable properties.
- Advancements in nanomaterials are creating new therapeutic avenues for cardiac conditions.
Purpose of the Study:
- To review nanoparticle-based therapies for cardiovascular diseases.
- To highlight the potential of polymer-based nanomaterials in CVD treatment.
- To outline essential knowledge and critical concerns in this field.
Main Methods:
- Review of current literature on nanoparticle applications in cardiology.
- Focus on polymer-based nanomaterials for drug delivery.
- Analysis of targeting strategies (active and passive) for cardiac tissues.
Main Results:
- Nanoparticles enable targeted drug delivery for conditions like atherosclerosis, hypertension, and myocardial infarction.
- Nanotechnology can potentially treat over 50% of CVDs efficiently.
- Polymer-based nanomaterials show significant promise in cardiac therapy.
Conclusions:
- Nanoparticle-based drug delivery is an effective strategy for cardiovascular disorders.
- Polymer nanomaterials represent a key area for future CVD therapeutic development.
- Further research is needed to address critical concerns in nanoparticle-based CVD treatment.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.3K
01:22Heart Failure VI: Adjunct Therapies
47
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:27Coronary Artery Disease V: Interprofessional Care
53
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
01:29Microorganisms in Medicine and Therapeutics
443
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
443
01:30Heart Failure V: Medical Management
38
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
38